Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children.

Literature DB >> 20808243

Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children.

Ariel E Feldstein, Valerio Nobili.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Biomarkers

Year: 2010 PMID： 20808243 PMCID： PMC2950320 DOI： 10.1097/MPG.0b013e3181ecf3d4

Source DB: PubMed Journal: J Pediatr Gastroenterol Nutr ISSN： 0277-2116 Impact factor: 2.839

× No keyword cloud information.

19 in total

1. High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.

Authors: Jason M Hui; Geoffrey C Farrell; James G Kench; Jacob George
Journal: Hepatology Date: 2004-05 Impact factor: 17.425

2. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.

Authors: Anna Wieckowska; Nizar N Zein; Lisa M Yerian; A Rocio Lopez; Arthur J McCullough; Ariel E Feldstein
Journal: Hepatology Date: 2006-07 Impact factor: 17.425

3. Childhood NAFLD: a ticking time-bomb?

Authors: Valerio Nobili; Chris Day
Journal: Gut Date: 2009-11 Impact factor: 23.059

4. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.

Authors: Elisabetta Bugianesi; Uberto Pagotto; Rita Manini; Ester Vanni; Amalia Gastaldelli; Rosaria de Iasio; Elena Gentilcore; Stefania Natale; Maurizio Cassader; Mario Rizzetto; Renato Pasquali; Giulio Marchesini
Journal: J Clin Endocrinol Metab Date: 2005-03-29 Impact factor: 5.958

5. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors: Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal: Gastroenterology Date: 2005-02 Impact factor: 22.682

6. Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD.

Authors: Emer Fitzpatrick; Ragai R Mitry; Alberto Quaglia; Munther J Hussain; Ruth DeBruyne; Anil Dhawan
Journal: J Pediatr Gastroenterol Nutr Date: 2010-10 Impact factor: 2.839

7. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors: David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal: Hepatology Date: 2005-06 Impact factor: 17.425

8. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years.

Authors: A E Feldstein; P Charatcharoenwitthaya; S Treeprasertsuk; J T Benson; F B Enders; P Angulo
Journal: Gut Date: 2009-07-21 Impact factor: 23.059

9. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.

Authors: Christine Carter-Kent; Lisa M Yerian; Elizabeth M Brunt; Paul Angulo; Rohit Kohli; Simon C Ling; Stavra A Xanthakos; Peter F Whitington; Phunchai Charatcharoenwitthaya; Jason Yap; Rocio Lopez; Arthur J McCullough; Ariel E Feldstein
Journal: Hepatology Date: 2009-10 Impact factor: 17.425

Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children.

1. High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.

2. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.

3. Childhood NAFLD: a ticking time-bomb?

4. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.

5. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

6. Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD.

7. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

8. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years.

9. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.

10. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Review 1. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Review 2. Pediatric non-alcoholic fatty liver disease: an increasing public health issue.

3. Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.

4. Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.